Ron Reid


About the Principal Investigator

E-mail: calm@interchange.ubc.ca
Phone/Fax: 604-822-4706

Training

Degree: B.S.P (Saskatchewan)
Degree: Ph.D. (London, England)

Current Position

Position: Professor

Selected Publications

  • Lakowski, T.M., Lee, G.M., Okon, M., Reid, R.E., McIntosh, L.P. (2007) Calcium-induced folding of a fragment of calmodulin composed of EF-hands 2 and 3. Protein Sci, 16(6): 1119-32.
  • Lakowski, T.M., Lee, G.M., Lelj-Garollla, B., Okon, M., Reid, R.E., McIntosh, L.P. (2007) Peptide binding by a fragment of calmodulin composed of EF-hands 2 and 3. Biochemistry, 46(29): 8525-36.
  • Reid, R.E. The Pharmacogenomics of Personalized Medicine. In “Preclinical Development Handbook - Toxicology”, Chapter 21, Shayne Cox Gad, editor, John Wiley and Sons, 2008.
  • Bains OS, Takahashi RH, Pfeifer TA, Grigliatti TA, Reid RE, Riggs KW. (2008)  Two allelic variants of aldo-keto reductase 1A1 exhibit reduced in vitro metabolism of daunorubicin.  Drug Metab Dispos. 36:904-910.
  • Takahashi RH, Bains OS, Pfeifer TA, Grigliatti TA, Reid RE, Riggs KW. (2008) Aldo-keto reductase 1C2 fails to metabolize doxorubicin and daunorubicin in vitro.  Drug Metab Dispos, 36:991-994.
  • Takahashi, R.H., Grigliatti, TA, Reid, RE, Riggs, KW (2009) The effect of allelic variation in aldo-keto reductase 1C2 on the in vitro metabolism of dihydrotestosterone. J Pharmacol Exp Ther, 329(3): p. 1032-9.
  • Bains, O.S., Karkling, MJ, Grigliatti, TA, Reid, RE, Riggs, KW (2009) Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin. Drug Metab Dispos. 37(5): p. 1107-14.

 

« Back



a place of mind, The University of British Columbia

Faculty of Pharmaceutical Sciences
2146 East Mall
Vancouver, BC, Canada V6T 1Z3
Tel (Dean’s Office): 604.822.2343

Emergency Procedures | Accessibility | Contact UBC | © Copyright The University of British Columbia